iwNHL 2020 Session IV
Novel Therapies Part II
Presentations
Novel BTK inhibitors: how to choose?
Tom Witzig, MD, Mayo Clinic Rochester, Rochester, MN
12 September, 2020
SINE inhibitors: Selinexor
John Kuruvilla, MD, FRCPC, The Princess Margaret Cancer Centre, Toronto, ON
12 September, 2020
Tafasitamab (MOR208) in DLBCL
Gilles Salles, MD, PhD, South Lyon Hospital, Lyon, France
12 September, 2020
